These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 39196799)

  • 1. Synergistic effects of glucose tolerance and BMI on cardiovascular events and all-cause mortality in a healthy population: CA.ME.LI.A study 7 years follow-up.
    Bignotto M; Bianco E; Centofanti L; Russo A; Dei Cas M; Zermiani P; Morano C; Samartin F; Bertolini E; Bifari F; Berra C; Zuin M; Paroni R; Battezzati PM; Folli F
    Am J Physiol Endocrinol Metab; 2024 Oct; 327(4):E498-E511. PubMed ID: 39196799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired fasting glucose and the risk of incident diabetes mellitus and cardiovascular events in an adult population: MESA (Multi-Ethnic Study of Atherosclerosis).
    Yeboah J; Bertoni AG; Herrington DM; Post WS; Burke GL
    J Am Coll Cardiol; 2011 Jul; 58(2):140-6. PubMed ID: 21718910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CA.ME.LI.A. An epidemiological study on the prevalence of CArdiovascular, MEtabolic, LIver and Autoimmune diseases in Northern Italy.
    Bignotto M; Dei Cas M; Paroni R; Bianco E; Zermiani P; Gangale MG; Zadro V; Maregatti M; Piagnani A; Russo A; Baldassarre D; Folli F; Battezzati PM; Zuin M
    Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1416-1426. PubMed ID: 33814235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study.
    Giordanino C; Bugianesi E; Smedile A; Ciancio A; Abate ML; Olivero A; Pellicano R; Cassader M; Gambino R; Bo S; Ciccone G; Rizzetto M; Saracco G
    Am J Gastroenterol; 2008 Oct; 103(10):2481-7. PubMed ID: 18702647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Risk Factors Affecting Impaired Fasting Glucose and Diabetes in Adult Patients from Northeast China.
    Yin Y; Han W; Wang Y; Zhang Y; Wu S; Zhang H; Jiang L; Wang R; Zhang P; Yu Y; Li B
    Int J Environ Res Public Health; 2015 Oct; 12(10):12662-78. PubMed ID: 26473900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The progression of cardiometabolic disease: validation of a new cardiometabolic disease staging system applicable to obesity.
    Guo F; Moellering DR; Garvey WT
    Obesity (Silver Spring); 2014 Jan; 22(1):110-8. PubMed ID: 23894121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome, glucose tolerance categories and the cardiovascular risk in Spanish population.
    Martínez-Larrad MT; Corbatón-Anchuelo A; Fernández-Pérez C; Lazcano-Redondo Y; Escobar-Jiménez F; Serrano-Ríos M
    Diabetes Res Clin Pract; 2016 Apr; 114():23-31. PubMed ID: 27103365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysglycemia and long-term mortality: observations from the Israel study of glucose intolerance, obesity and hypertension.
    Bergman M; Chetrit A; Roth J; Dankner R
    Diabetes Metab Res Rev; 2015 May; 31(4):368-75. PubMed ID: 25352076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic syndrome predicts cardiovascular events in subjects with normal fasting glucose: results of a 15 years follow-up in a Mediterranean population.
    Noto D; Barbagallo CM; Cefalù AB; Falletta A; Sapienza M; Cavera G; Amato S; Pagano M; Maggiore M; Carroccio A; Notarbartolo A; Averna MR
    Atherosclerosis; 2008 Mar; 197(1):147-53. PubMed ID: 17466306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal association and sexual dysfunction in patients with impaired fasting glucose: a cross-sectional and longitudinal study.
    Corona G; Rastrelli G; Balercia G; Lotti F; Sforza A; Monami M; Forti G; Mannucci E; Maggi M
    J Sex Med; 2012 Jun; 9(6):1669-80. PubMed ID: 22489756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose levels are associated with cardiovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the EpiDREAM cohort study.
    Anand SS; Dagenais GR; Mohan V; Diaz R; Probstfield J; Freeman R; Shaw J; Lanas F; Avezum A; Budaj A; Jung H; Desai D; Bosch J; Yusuf S; Gerstein HC;
    Eur J Prev Cardiol; 2012 Aug; 19(4):755-64. PubMed ID: 21551215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Situation of impaired glucose regulation and metabolic syndrome in overweight or obesity adolescent students in Dongguan city].
    Peng YQ; Nie WM; Chen JG; Tang HM; Cao T; Lin YX
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jun; 43(6):495-500. PubMed ID: 19950716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired Fasting Glucose Is the Major Determinant of the 20-Year Mortality Risk Associated With Metabolic Syndrome in Nondiabetic Patients With Stable Coronary Artery Disease.
    Younis A; Goldkorn R; Goldenberg I; Geva D; Tzur B; Mazu A; Younis A; Fisman Z; Tannenbaum A; Klempfner R
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of change in fasting glucose on the risk of myocardial infarction, stroke, and all-cause mortality: a nationwide cohort study.
    Lee G; Kim SM; Choi S; Kim K; Jeong SM; Son JS; Yun JM; Park SM
    Cardiovasc Diabetol; 2018 Apr; 17(1):51. PubMed ID: 29626936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
    Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
    Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between BMI and risk of impaired glucose tolerance and impaired fasting glucose in Chinese adults: a prospective study.
    Zhang X; Yue Y; Liu S; Cong X; Wang W; Li J
    BMC Public Health; 2023 Jan; 23(1):14. PubMed ID: 36597050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk and population attributable fraction of metabolic syndrome and impaired fasting glucose for the incidence of type 2 diabetes mellitus among middle-aged Japanese individuals: Aichi Worker's Cohort Study.
    Kaneko K; Yatsuya H; Li Y; Uemura M; Chiang C; Hirakawa Y; Ota A; Tamakoshi K; Aoyama A
    J Diabetes Investig; 2020 Sep; 11(5):1163-1169. PubMed ID: 32022993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in Fasting plasma glucose status and risk of mortality events in individuals without diabetes over two decades of Follow-up: a pooled cohort analysis.
    Kohansal K; Masrouri S; Khalili D; Ramezankhani A; Azizi F; Blaha MJ; Hadaegh F
    Cardiovasc Diabetol; 2022 Dec; 21(1):267. PubMed ID: 36463152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of traits of metabolic syndrome with glucose abnormalities.
    Hoffmann IS; Cubeddu LX
    Am J Ther; 2013; 20(4):363-8. PubMed ID: 23591026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between cardiorespiratory fitness and risk of all-cause mortality among women with impaired fasting glucose or undiagnosed diabetes mellitus.
    Lyerly GW; Sui X; Lavie CJ; Church TS; Hand GA; Blair SN
    Mayo Clin Proc; 2009 Sep; 84(9):780-6. PubMed ID: 19720775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.